In diabetic complications, hyperglycemia is shown to accelerate MI catabolism via MIOX upregulation, resulting in toxic metabolite accumulation (e.g., xylitol) and exacerbation of retinal and neural tissue damage, thereby positioning MIOX as a potential therapeutic target for diabetic complications [83]. Here, MIOX is linked to Hyperglycemia.